Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2/3 1

Status

Completed 2Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Glioblastoma 5Carcinoma, Non-Small-Cell Lung 5Rectal Neoplasms 4Head and Neck Neoplasms 4Esophageal Neoplasms 4Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Glioma 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Astrocytoma 3Sarcoma 2Pancreatic Neoplasms 2Osteosarcoma 2Lung Neoplasms 2Carcinoma, Squamous Cell 2Brain Neoplasms 2Wilms Tumor 1Urinary Bladder Neoplasms 1Skin Neoplasms 1Sinonasal Squamous Cell Carcinoma 1Rhabdomyosarcoma 1Recurrence 1Radiation Injuries 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Postoperative Complications 1Pilonidal Sinus 1

Interventions

Fulvestrant 64Letrozole 54Paclitaxel 49Trastuzumab 41pembrolizumab 40ribociclib 37Specimen Handling 37palbociclib 36Capecitabine 34Anastrozole 34Carboplatin 33Tamoxifen 32exemestane 30pertuzumab 28abemaciclib 28Magnetic Resonance Spectroscopy 26Cyclophosphamide 26trastuzumab deruxtecan 24Surveys and Questionnaires 21Biopsy 19Radiotherapy 18olaparib 17Blood Specimen Collection 17Standard of Care 16Docetaxel 16Taxes 14Mastectomy, Segmental 14eribulin 13elacestrant 13Methods 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Breast Neoplasms × Surgical Procedures, Operative × 90 days × Clear all
NCT02364557 2026-05-19

Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

NRG Oncology

Phase 2/3 Completed
129 enrolled 23 charts
Breast

Breast Neoplasms, Lymphatic Metastasis

NCT07586319 2026-05-19

SASI-MBC

Sharif Medical Research Center

Phase NA Enrolling by invitation
110 enrolled
Breast

Breast Neoplasms

NCT00911911 2026-03-13

SPAM

Centre Oscar Lambret

Phase NA Completed
66 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡